Solid Total Revenue from 2010 to 2025
| SLDB Stock | USD 4.13 0.13 3.25% |
Total Revenue | First Reported 2015-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 2.1 M |
Check Solid Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Solid Biosciences' main balance sheet or income statement drivers, such as Interest Income of 8.5 M, Interest Expense of 24.7 M or Selling General Administrative of 20.8 M, as well as many indicators such as Price To Sales Ratio of 10.66, Dividend Yield of 0.0 or PTB Ratio of 0.91. Solid financial statements analysis is a perfect complement when working with Solid Biosciences Valuation or Volatility modules.
Solid | Total Revenue |
Latest Solid Biosciences' Total Revenue Growth Pattern
Below is the plot of the Total Revenue of Solid Biosciences LLC over the last few years. Total revenue comprises all receipts Solid Biosciences LLC generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Solid Biosciences' Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Solid Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Total Revenue | 10 Years Trend |
|
Total Revenue |
| Timeline |
Solid Total Revenue Regression Statistics
| Arithmetic Mean | 1,565,562 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 246.24 | |
| Mean Deviation | 2,544,039 | |
| Median | 0.00 | |
| Standard Deviation | 3,855,072 | |
| Sample Variance | 14.9T | |
| Range | 13.6M | |
| R-Value | 0.34 | |
| Mean Square Error | 14.1T | |
| R-Squared | 0.11 | |
| Significance | 0.20 | |
| Slope | 271,854 | |
| Total Sum of Squares | 222.9T |
Solid Total Revenue History
About Solid Biosciences Financial Statements
Solid Biosciences stakeholders use historical fundamental indicators, such as Solid Biosciences' Total Revenue, to determine how well the company is positioned to perform in the future. Although Solid Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Solid Biosciences' assets and liabilities are reflected in the revenues and expenses on Solid Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Solid Biosciences LLC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| S | SentinelOne | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Check out the analysis of Solid Biosciences Correlation against competitors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.